Berenberg Bank Cuts Oxford Nanopore Technologies (LON:ONT) Price Target to GBX 220

Oxford Nanopore Technologies (LON:ONT) had its price objective lowered by analysts at Berenberg Bank from GBX 230 to GBX 220 in a note issued to investors on Monday,Digital Look reports. The firm presently has a “buy” rating on the stock. Berenberg Bank’s price target would indicate a potential upside of 107.74% from the company’s current price.

Several other analysts have also recently issued reports on the company. Royal Bank Of Canada restated an “outperform” rating and issued a GBX 225 target price on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Citigroup cut shares of Oxford Nanopore Technologies to a “buy” rating in a research report on Friday. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Oxford Nanopore Technologies currently has a consensus rating of “Moderate Buy” and an average price target of GBX 212.60.

Oxford Nanopore Technologies Price Performance

ONT stock opened at GBX 105.90 on Monday. Oxford Nanopore Technologies has a 1 year low of GBX 95.61 and a 1 year high of GBX 224.80. The company has a debt-to-equity ratio of 8.96, a current ratio of 3.56 and a quick ratio of 6.01. The firm has a market capitalization of £1.03 billion, a PE ratio of -7.01 and a beta of 0.92. The business has a 50 day simple moving average of GBX 123.34 and a 200-day simple moving average of GBX 128.12.

Insiders Place Their Bets

In other Oxford Nanopore Technologies news, insider Nick Keher sold 22,993 shares of the stock in a transaction dated Tuesday, April 14th. The shares were sold at an average price of GBX 108, for a total transaction of £24,832.44. Insiders have bought a total of 22,799 shares of company stock worth $2,578,133 over the last ninety days. Company insiders own 2.54% of the company’s stock.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.